I've walked thru the economic logic here, but Gilead obviously does not say this out loud. They don't really have a good reason not to sell to MSF, which is why they landed on negotiating supply contracts is "a lot of work" (actual thing they said). 13/
www.doctorswithoutborders.org/latest/preve...
www.doctorswithoutborders.org
MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.
